Archives: Agenda

The landscape of clinical trials is undergoing a transformative shift as digital technologies continue to permeate every aspect of the healthcare industry. One potential transformation could be the replacement of traditional paper-based relabelling in clinical trials with digital display labels. The integration of digital display labels into clinical trials represents a significant leap forward in the industry. As this technology matures and becomes more widely adopted, it could impact the way clinical trials are conducted and managed especially in the areas of remote monitoring, adaptive trials, and patient engagement. In this session, we will explore the challenges associated with traditional relabelling processes in clinical trials, the advantages of adopting digital display labels, and the potential impact on the future of healthcare research.

This session will include demonstrations and case study data illustrating how novel, effective technology-driven strategies can remove workflow friction and improve project delivery across several clinical workflows that are complex and dynamic, requiring multi-stakeholder inputs and timely, complex data exchanges.  In this session, you will learn how to optimize your processes for patient eligibility review, remote monitoring and more – all in one collaboration platform!

• Addressing the loss of innovative work due to biotechs ceasing to exist
• Discussing the increase in M&A (Mergers & Acquisitions)
• CRO hub’s role in managing various entities

As an industry, it is essential to continuously bring on new sites and new physicians, ensuring they do not become a one-and-done site or Principal Investigator (PI). Therefore, Endo will share strategies to help sponsors find effective ways to guide naive sites on where to start in clinical research and support them every step of the way, from pre-study visits to study closure. Part of the strategies include the inclusion of a Site Relationship Manager role at Endo.